TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Novartis Norge AS
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,227,897
|
1,382,510
|
1,313,302 |
Financial expenses |
817
|
888
|
1,980 |
Earnings before taxes |
40,884
|
59,643
|
49,662 |
Total assets |
626,370
|
453,527
|
477,580 |
Current assets |
616,318
|
450,703
|
471,427 |
Current liabilities |
352,880
|
218,978
|
254,676 |
Equity capital |
273,125
|
234,089
|
174,789 |
- share capital |
1,586
|
1,538
|
1,432 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
43.6%
|
51.6%
|
36.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
3.3%
|
4.3%
|
3.8% |
Return on assets (ROA) |
6.7%
|
13.3%
|
10.8% |
Current ratio |
174.7%
|
205.8%
|
185.1% |
Return on equity (ROE) |
15.0%
|
25.5%
|
28.4% |
Change turnover |
-197,451
|
-28,263
|
-6,399 |
Change turnover % |
-14%
|
-2%
|
0% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.